Diclofenac Sodium
Product Images NDC 70934-687

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 70934-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 687 30 Master Bottle Label Approval Rev A 04 20)

Packaging label for Diclofenac Sodium Delayed-Release Tablets, USP 50 mg, containing 30 tablets. The label includes dosage and storage instructions, emphasizing excursions permitted between 30°C to 59°C and protection from moisture. The product is labeled Rx only and is supplied by Denton Pharma, Inc. DBA Northwind Pharmaceuticals, with NDC 70934-687-30.*

FDA Label Image

1 (Image 1)

Chemical structure of Diclofenac Sodium showing its molecular arrangement with two chlorine atoms attached to one benzene ring, an amine group linking the rings, and a carboxylate group bonded to sodium.*

FDA Label Image

Logo (Image 2)

Diclofenac Sodium tablet packaging label from Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label shows the product name "Diclofenac Sodium," dosage form as tablets, and includes other details such as strength and tablet count not visible in the image. The label also includes the NDC number 70934-687.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.